Hypoglycemia is a key risk factor and a major barrier in Diabetes management. Hypoglycemia events is a burden on health care systems due to the high cost of hypoglycemia-related emergency visits and hospitalizations. Dario, a digital Diabetes management system, may assist patients to reduce hypoglycemia events and glycemic control in users under insulin treatment.
A retrospective data analysis was performed on the Dario real-world database.
A population of 1,481 users under insulin therapy with type 1 and type 2 Diabetes that were using Dario over two years was evaluated.
Average numbers of level 1 hypoglycemia (<70mg/dL) and level 2 hypoglycemia (<54 mg/dL) events were calculated monthly and compared to baseline (first month).
Continuous reduction in hypoglycemia events was observed throughout the 2 years period.
Average level 1 hypoglycemia events was reduced by 24% and 50% from baseline (1.39, 0.91 vs. 1.82 average events/month) after 6 months and after 2 years, respectively. Average level 2 hypoglycemia events were reduced by 16% and 56% from baseline (0.35, 0.18 vs. 0.42) after 6 months and after 2 years, respectively. Subgroup analyses of users with type 1 Diabetes (n=363) revealed substantial reduction of level 1 hypoglycemia events of 50% (2.5 vs. 5.0) and level 2 hypoglycemia of 55% (0.62 vs. 1.39) after 2 years. Moreover, a high reduction in hyper events was recorded as well.
To conclude: Patients using a digital Diabetes management platform have the potential to
improve their glycemic outcome and reduce emergency events and hospitalization.